The Lung Institute recently led a discussion in Italy on both the present and potential future applications of stem cell therapy. The discussion was a part of the larger Third International Congress on Responsible Stem Cell Research meeting and primarily focused on the efforts of the Lung Institute’s Jack Coleman, as well as that of his team.
Although stem cell research has progressed considerably over the years, there is still plenty for the United States, and other countries, to learn about its application. For instance, Dr. Coleman of the Baylor College of Medicine noted in his discussion that current medical practices are simply too slow and expensive to keep up with the rate of advances being made in stem cell research. During his presentation, he walked the audience through the clinical trial process, and how certain regulations could prevent patients from getting access to viable stem cell treatments. Although his presentation was largely directed at the American way of conducting stem cell research, he also looked at a few other countries as well, so as to compare and contrast any alternatives.
Interestingly, the overarching theme of this year’s event was “Development of New Therapeutic Tools.” In that regard, it was appropriate for Dr. Coleman to look at exactly how stem cell research translates into new treatment methods, as well the impact that regulatory agents were having on their progress.
As for the Lung Institute itself, it remains one of the most advanced providers of medicinal cell therapies, with a primary focus on lung diseases such as pulmonary fibrosis, chronic obstructive pulmonary disease, and interstitial lung disease. In addition to working with patients on these issues, the Lung Institute is also responsible for operating clinics in Florida, Arizona, Pennsylvania, and Texas. Since the institute’s founding, there has been a substantial increase in the quality of life for patients suffering from these diseases, as well as a considerable rise in their treatment rates. And, it seems, the Lung Institute shows no signs of slowing down its success rates, as long as they continue to study the development of new stem cell therapies. The Lung Institute website has numerous testimonials and inquiries from people with COPD who want to know more about how stem cell therapy works